Complete Genomics Posts Q2 Revenues of $1.1M

In an amended S-1, the company which filed for an IPO in July, said its net loss rose to $12.6 million, and start-up costs increased seven-fold to $4.9 million.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories